The vasodilatory effect of juxta-arteriolar microinjection of endothelinA receptor inhibitor in healthy and acute branch retinal vein occlusion minipig retinas

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 4, 2010, Pages 2185-2190

  Stangos, Alexandros N ^a   Petropoulos, Ioannis K ^a   Pournaras, Jean Antoine C ^b   Mendrinos, Efstratios ^a   Pournaras, Constantin J ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; CYCLO(TRP ASP PRO VAL LEU); CYCLO(TRP-ASP-PRO-VAL-LEU); CYCLOPEPTIDE; ENDOTHELIN A RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DIAMETER; ARTERY TONE; ARTICLE; CONTROLLED STUDY; JUXTA ARTERIOLAR MICROINJECTION; MICROINJECTION; MINIPIG; NONHUMAN; PRIORITY JOURNAL; RETINA; RETINA BLOOD VESSEL; RETINA VEIN OCCLUSION; VASOCONSTRICTION; VASODILATATION; ACUTE DISEASE; ANIMAL; ARTERIOLE; DISEASE MODEL; DRUG ANTAGONISM; PATHOPHYSIOLOGY; PHYSIOLOGY; RETINA ARTERY; SWINE; VASCULAR SMOOTH MUSCLE;

ACUTE DISEASE; ANIMALS; ARTERIOLES; DISEASE MODELS, ANIMAL; ENDOTHELIN-1; MICROINJECTIONS; MUSCLE, SMOOTH, VASCULAR; PEPTIDES, CYCLIC; RECEPTOR, ENDOTHELIN A; RETINAL ARTERY; RETINAL VEIN OCCLUSION; SWINE; SWINE, MINIATURE; VASODILATION;

EID: 77951210649     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-3735     Document Type: Article

References (52)

1. Pournaras CJ, Rungger-Brandle E, Riva CE, et al. Regulation of retinal blood flow in health and disease. Prog Retin Eye Res. 2008;27(3):284-330.
2. Brown SM, Jampol LM. New concepts of regulation of retinal vessel tone. Arch Ophthalmol. 1996;114(2):199-204.
3. Haefliger IO, Meyer P, Flammer J, Luscher TF. The vascular endothelium as a regulator of the ocular circulation: a new concept in ophthalmology? Surv Ophthalmol. 1994;39(2):123-132.
4. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332(6163):411-415.
5. Levin ER. Endothelins. N Engl J Med. 1995;333(6):356-363.
6. Rubanyi GM, Polokoff MA. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev. 1994;46(3):325-415.
7. Ripodas A, de Juan JA, Roldan-Pallares M, et al. Localisation of endothelin-1 mRNA expression and immunoreactivity in the retina and optic nerve from human and porcine eye: evidence for endothelin- 1 expression in astrocytes. Brain Res. 2001;912(2):137-143.
8. MacCumber MW, D'Anna SA. Endothelin receptor-binding subtypes in the human retina and choroid. Arch Ophthalmol. 1994; 112(9):1231-1235.
9. McDonald DM, Bailie JR, Archer DB, Chakravarthy U. Characterization of endothelin A (ETA) and endothelin B (ETB) receptors in cultured bovine retinal pericytes. Invest Ophthalmol Vis Sci. 1995; 36(6):1088-1094.
10. Emre M, Orgul S, Haufschild T, et al. Increased plasma endothelin- 1 levels in patients with progressive open angle glaucoma. Br J Ophthalmol. 2005;89(1):60-63.
11. Schmetterer L, Wolzt M. Ocular blood flow and associated functional deviations in diabetic retinopathy. Diabetologia. 1999; 42(4):387-405.
12. Deng D, Evans T, Mukherjee K, et al. Diabetes-induced vascular dysfunction in the retina: role of endothelins. Diabetologia. 1999; 42(10):1228-1234.
13. Iannaccone A, Letizia C, Pazzaglia S, et al. Plasma endothelin-1 concentrations in patients with retinal vein occlusions. Br J Ophthalmol. 1998;82(5):498-503.
14. Haufschild T, Prunte C, Messerli J, Flammer J. Increased endothelin- 1 plasma level in young adults with retinal vascular occlusive diseases. Klin Monatsbl Augenheilkd. 2004;221(5):357-359.
15. Rolinski B, Geier SA, Sadri I, et al. Endothelin-1 immunoreactivity in plasma is elevated in HIV-1 infected patients with retinal microangiopathic syndrome. Clin Investig. 1994;72(4):288-293.
16. Haufschild T, Shaw SG, Kaiser HJ, Flammer J. Transient raise of endothelin-1 plasma level and reduction of ocular blood flow in a patient with optic neuritis. Ophthalmologica. 2003;217(6):451-453.
17. Polak K, Luksch A, Frank B, et al. Regulation of human retinal blood flow by endothelin-1. Exp Eye Res. 2003;76(5):633-640.
18. Beauchemin ML. The fine structure of the pig's retina. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1974;190(1):27-45.
19. Bloodworth JM Jr, Gutgesell HP Jr, Engerman RL. Retinal vasculature of the pig: light and electron microscope studies. Exp Eye Res. 1965;4(3):174-178.
20. Pournaras CJ, Riva CE, Tsacopoulos M, Strommer K. Diffusion of O2 in the retina of anesthetized miniature pigs in normoxia and hyperoxia. Exp Eye Res. 1989;49(3):347-360.
21. Mendrinos E, Petropoulos IK, Mangioris G, et al. Lactate-induced retinal arteriolar vasodilation implicates neuronal nitric oxide synthesis in minipigs. Invest Ophthalmol Vis Sci. 2008;49(11):5060-5066.
22. Jeppesen P, Sanye-Hajari J, Bek T. Increased blood pressure induces a diameter response of retinal arterioles that increases with decreasing arteriolar diameter. Invest Ophthalmol Vis Sci. 2007; 48(1):328-331.
23. Wilson CA, Hatchell DL. Photodynamic retinal vascular thrombosis: rate and duration of vascular occlusion. Invest Ophthalmol Vis Sci. 1991;32(8):2357-2365.
24. Zhang X, Ma Z, Hu Y, Fan J. Direct tissue plasminogen activator administration through a microinjection device in a pig model of retinal vein thrombosis. Curr Eye Res. 2002;24(4):263-267.
25. Polak K, Dorner G, Kiss B, et al. Evaluation of the Zeiss retinal vessel analyser. Br J Ophthalmol. 2000;84(11):1285-1290.
26. Seifertl BU, Vilser W. Retinal Vessel Analyzer (RVA): design and function. Biomed Tech (Berl). 2002;47(suppl 1):678-681.
27. Vilser W, Nagel E, Lanzl I. Retinal Vessel Analysis: new possibilities. Biomed Tech (Berl). 2002;47(suppl 1):682-685.
28. Arai H, Hori S, Aramori I, et al. Cloning and expression of a cDNA encoding an endothelin receptor. Nature. 1990;348(6303):730-732.
29. Takagi C, Bursell SE, Lin YW, et al. Regulation of retinal hemodynamics in diabetic rats by increased expression and action of endothelin-1. Invest Ophthalmol Vis Sci. 1996;37(12):2504-2518.
30. Bursell SE, Clermont AC, Oren B, King GL. The in vivo effect of endothelins on retinal circulation in nondiabetic and diabetic rats. Invest Ophthalmol Vis Sci. 1995;36(3):596-607.
31. Granstam E, Wang L, Bill A. Ocular effects of endothelin-1 in the cat. Curr Eye Res. 1992;11(4):325-332.
32. Takei K, Sato T, Nonoyama T, et al. A new model of transient complete obstruction of retinal vessels induced by endothelin-1 injection into the posterior vitreous body in rabbits. Graefes Arch Clin Exp Ophthalmol. 1993;231(8):476-481.
33. Marsen TA, Simonson MS, Dunn MJ. Thrombin induces the preproendothelin- 1 gene in endothelial cells by a protein tyrosine kinase-linked mechanism. Circ Res. 1995;76(6):987-995.
34. Metsarinne K, Nordstrom D, Santavirta S, et al. Effects of prolonged tourniquet ischaemia and short-term venous stasis on plasma endothelin-1 levels in man. Scand J Clin Lab Invest. 1995;55(3):251-256.
35. Wagner OF, Nowotny P, Vierhapper H, Waldhausl W. Plasma concentrations of endothelin in man: arterio-venous differences and release during venous stasis. Eur J Clin Invest. 1990;20(5): 502-505.
36. Gertler JP, Ocasio VH. Endothelin production by hypoxic human endothelium. J Vasc Surg. 1993; 18(2):178-82 discussion 82-84.
37. Kourembanas S, Marsden PA, McQuillan LP, Faller DV. Hypoxia induces endothelin gene expression and secretion in cultured human endothelium. J Clin Invest. 1991;88(3):1054-1057.
38. Rakugi H, Tabuchi Y, Nakamaru M, et al. Evidence for endothelin-1 release from resistance vessels of rats in response to hypoxia. Biochem Biophys Res Commun. 1990;169(3):973-977.
39. Desai D, He S, Yorio T, et al. Hypoxia augments TNF-alpha-mediated endothelin-1 release and cell proliferation in human optic nerve head astrocytes. Biochem Biophys Res Commun. 2004; 318(3):642-648.
40. Wise GN. Arteriosclerosis secondary to retinal vein obstruction. Trans Am Ophthalmol Soc. 1958; 56: 361-380, discussion 80-82.
41. Rosen DA, Marshall J, Kohner EM, et al. Experimental retinal branch vein occlusion in rhesus monkeys, II: retinal blood flow studies. Br J Ophthalmol. 1979;63(6):388-392.
42. Lopez JA, Armstrong ML, Piegors DJ, Heistad DD. Vascular responses to endothelin-1 in atherosclerotic primates. Arteriosclerosis. 1990;10(6):1113-1118.
43. Donati G, Pournaras CJ, Pizzolato GP, Tsacopoulos M. Decreased nitric oxide production accounts for secondary arteriolar constriction after retinal branch vein occlusion. Invest Ophthalmol Vis Sci. 1997;38(7):1450-1457.
44. Donati G, Pournaras CJ, Tsacopoulos M. Effect of nitropruside on arteriolar constriction after retinal branch vein occlusion. Invest Ophthalmol Vis Sci. 1998;39(10):1910-1917.
45. Letizia C, Iannaccone A, Cerci S, et al. Circulating endothelin-1 in non-insulin-dependent diabetic patients with retinopathy. Horm Metab Res. 1997;29(5):247-251.
46. Rodeheffer RJ, Lerman A, Heublein DM, Burnett JC Jr. Increased plasma concentrations of endothelin in congestive heart failure in humans. Mayo Clin Proc. 1992;67(8):719-724.
47. Stewart DJ, Kubac G, Costello KB, Cernacek P. Increased plasma endothelin-1 in the early hours of acute myocardial infarction. J Am Coll Cardiol. 1991;18(1):38-43.
48. Hollo G. Plasma endothelial-1 concentrations in patients with retinal vein occlusions. Br J Ophthalmol. 1999;83(1):127-128.
49. Meyer P, Flammer J, Luscher TF. Endothelium-dependent regulation of the ophthalmic microcirculation in the perfused porcine eye: role of nitric oxide and endothelins. Invest Ophthalmol Vis Sci. 1993;34(13):3614-3621.
50. Haynes WG, Webb DJ. Contribution of endogenous generation of endothelin-1 to basal vascular tone. Lancet. 1994;344(8926):852-854.
51. Luksch A, Wimpissinger B, Polak K, Jandrasits K, Schmetterer L. ETa-receptor blockade, but not ACE inhibition, blunts retinal vessel response during isometric exercise. Am J Physiol Heart Circ Physiol. 2006;290(4):H1693-H1698.
52. Guyton AC JC, Coleman TG. Circulatory Physiology: Cardial Output and Its Regulation. Philadelphia: WB Saunders; 1973;323-352.